Virogenomics, Inc. is a privately held Oregon-based biotechnology company whose business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies.


Virus-Induced Transformation of Human Endothelial Cells